相关实验视频
Updated: Jul 13, 2025
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.5K
多发性硬化症治疗的内部并发症和并发症 - 不要被忽视!
Vnitrni lekarstvi
|October 12, 2023
概括
多发性硬化症 (MS) 是一种影响年轻成年人的中枢神经系统自身免疫性疾病. 管理并发症和早期治疗是关键,但治疗副作用和相互作用需要谨慎的跨学科管理.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 多发性硬化症 (MS) 是一种慢性自身免疫性中枢神经系统疾病,在年轻人中普遍存在.
- 伴随性疾病如神经,精神,心血管,代谢和自身免疫疾病在MS患者中很常见.
- 伴随性疾病管理显著影响多发性硬化症的病程,具有潜在的双向效应.
研究的目的:
- 探索多发性硬化症及其并发症之间的复杂相互作用.
- 讨论治疗策略,考虑共同的风险因素和免疫病原发生.
- 突出与疾病修饰疗法相关的风险和跨学科护理的重要性.
主要方法:
- 关于MS,并发症和治疗影响的文献综述.
- 分析常见的并发症及其对MS进展的影响.
- 检查治疗方法,包括共享治疗和潜在的药物相互作用.
主要成果:
- 早期的抗炎治疗和并发症管理对MS的发展有积极的影响.
- 多发性硬化不补偿会使相关疾病恶化,反之亦然.
- 多发性硬化症的治疗可能会增加其他自身免疫性疾病,感染和恶性瘤的风险.
结论:
- 综合性并发症的综合管理对于优化多发性硬化症患者的治疗结果至关重要.
- 必须仔细考虑治疗副作用和药物相互作用.
- 专家之间的密切跨学科合作对于有效的MS护理至关重要.
相关概念视频
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:29Pulmonary Tuberculosis I
247
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
247
01:28Drug Therapy
49
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
49
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16